Lookup NU author(s): Dr Nick Steen,
Professor Pamela Shaw
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2015 Informa Healthcare. Amyotrophic lateral sclerosis (ALS) is a devastating neurological syndrome in which motor neurons degenerate relentlessly. Although the site of onset and the rate of spread have been studied extensively, little is known about whether focal as opposed to diffuse disease affects prognosis. We therefore tested the hypothesis that regionality of disease burden is a prognostic factor in ALS. We analysed clinical data from two large multicentre, longitudinal trials. Regionality was defined as the difference in progression rates in three domains as measured by the revised ALS Functional Rating Scale, omitting the respiratory domain from analysis. We used death by trial end as the outcome variable and tested this by logistic regression against predictor variables including regionality and overall rate of disease progression. There were 561 patients. Regionality of disease was independently associated with significantly higher chance of death by study end (odds ratio most diffuse against most focal category 0.354 (0.191, 0.657), p = 0.001), with a direct relationship between degree of regionality and odds of death. We have shown using clinical trial data that focal disease is associated with a worse prognosis in ALS. Measures of regionality warrant further independent consideration in the development of future prognostic models.
Author(s): Van Der Kleij LA, Jones AR, Steen IN, Young CA, Shaw PJ, Shaw CE, Leigh PN, Turner MR, Al-Chalabi A
Publication type: Article
Publication status: Published
Journal: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Online publication date: 17/06/2015
Acceptance date: 12/04/2015
ISSN (print): 2167-8421
ISSN (electronic): 2167-9223
Publisher: Taylor and Francis Ltd
Altmetrics provided by Altmetric